Contribution of Real‐World Evidence in European Medicines Agency's Regulatory Decision Making.

MLA

Bakker, Elisabeth, et al. “Contribution of Real‐World Evidence in European Medicines Agency’s Regulatory Decision Making.” Clinical Pharmacology & Therapeutics, vol. 113, no. 1, Jan. 2023, pp. 135–51. EBSCOhost, https://doi.org/10.1002/cpt.2766.

APA

Bakker, E., Plueschke, K., Jonker, C. J., Kurz, X., Starokozhko, V., & Mol, P. G. M. (2023). Contribution of Real‐World Evidence in European Medicines Agency’s Regulatory Decision Making. Clinical Pharmacology & Therapeutics, 113(1), 135–151. https://doi.org/10.1002/cpt.2766

Chicago

Bakker, Elisabeth, Kelly Plueschke, Carla J. Jonker, Xavier Kurz, Viktoriia Starokozhko, and Peter G. M. Mol. 2023. “Contribution of Real‐World Evidence in European Medicines Agency’s Regulatory Decision Making.” Clinical Pharmacology & Therapeutics 113 (1): 135–51. doi:10.1002/cpt.2766.